In an unusual move, the FDA has approved the diabetes drug Symlin on condition of a series of heavy advertising restrictions. The agreement between the agency and manufacturer Amylin calls for a ban ...
Scientists will mix insulin with Amylin Pharmaceuticals’ diabetes drug Symlin to see if the combination injection works as well at controlling blood sugar levels as separately injected doses of the ...
SAN FRANCISCO — The chief executive of Amylin Pharmaceuticals Inc. on Monday said the company was in talks with the Food and Drug Administration about its beleaguered experimental diabetes drug Symlin ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In patients with type 1 diabetes, the use of Symlin ...
Regulators approved Amylin Pharmaceuticals Inc.’s diabetes drug Symlin on Wednesday after an 18-year quest that investors had once written off as hopeless. It was the first Food and Drug ...
Amylin's battle to get Symlin approved was long and difficult, but success will have its rewards. "...But I'll wait for something more, Yes I've got to have faith..." -- George Michael, "Faith" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results